{
    "accession": "ENCBS472YQF",
    "age": "53",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "deletion",
            "method": "CRISPR",
            "modified_site_by_target_id": "IGF2BP1",
            "purpose": "repression"
        }
    ],
    "biosample_term_id": "EFO:0002067",
    "biosample_term_name": "K562",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "RNA-seq on K562 cells treated with a CRISPR gRNA against IGF2BP1. (IGF2BP1_BGKcLV02-3)",
    "documents": [
        {
            "attachment": "/documents/24b67f9c-c791-4a2a-a33b-419794e4681a/@@download/attachment/Graveley-K562-growth-protocol.pdf",
            "document_type": "growth protocol",
            "references": [],
            "urls": []
        },
        {
            "attachment": "/documents/836de75c-a2f2-4c15-ad99-e8bab3d0bc0d/@@download/attachment/IGF2BP1_BGKcLV02-3.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAD",
    "health_status": "chronic myelogenous leukemia (CML)",
    "lab": "Brenton Graveley, UConn",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "female",
    "source": "ATCC",
    "summary": "Homo sapiens K562 cell line genetically modified (deletion) using CRISPR targeting IGF2BP1",
    "treatments": []
}